Recent research has determined that while these proteins are implicated in the pathophysiology of AD, mechanisms by which Aβ and tau accumulate in the brain are thought to be due to the impaired clearance of proteins and other toxins by the glymphatic system (Jessen et al., 2015), and its Perivascular Spaces (PVS). Here, MAPT is linked to Alzheimer disease.